Drug
TAK-994
TAK-994 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 60.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
60.0%
Based on 3 completed trials
Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Terminated
2(40%)
Phase Distribution
Ph phase_1
3
60%
Ph phase_2
2
40%
Phase Distribution
3
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
Phase 2Efficacy & side effects
2(40.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
60.0%
3 of 5 finished
Non-Completion Rate
40.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(2)
Detailed Status
Completed3
Terminated2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
60.0%
Most Advanced
Phase 2
Trials by Phase
Phase 13 (60.0%)
Phase 22 (40.0%)
Trials by Status
completed360%
terminated240%
Recent Activity
0 active trials
Showing 5 of 5
terminatedphase_2
A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy
NCT04096560
terminatedphase_2
A Study of TAK-994 in Adults With Narcolepsy
NCT04820842
completedphase_1
A Study of Different Forms of TAK-994 in Healthy Adults
NCT04745767
completedphase_1
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics (PK) of Oral TAK-994 in an Acute Sleep Phase Delay Paradigm in Healthy Male Participants
NCT04551079
completedphase_1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Healthy Participants
NCT03933488
Clinical Trials (5)
Showing 5 of 5 trials
NCT04096560Phase 2
A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy
NCT04820842Phase 2
A Study of TAK-994 in Adults With Narcolepsy
NCT04745767Phase 1
A Study of Different Forms of TAK-994 in Healthy Adults
NCT04551079Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics (PK) of Oral TAK-994 in an Acute Sleep Phase Delay Paradigm in Healthy Male Participants
NCT03933488Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Healthy Participants
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5